| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A clinical trial of zosuquidar plus gemtuzumab ozogamicin (GO) in relapsed or refractory acute myeloid leukemia (RR AML): evidence of efficacy based on leukemic blast P-glycoprotein functional phenotype
|
Marcelletti, John F.
|
|
|
92 |
5 |
p. 369-380
|
article
|
| 2 |
Chemotherapy periodization to maximize resistance training adaptations in oncology
|
Nunes, Jonathan H. C.
|
|
|
92 |
5 |
p. 357-367
|
article
|
| 3 |
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer
|
Nakahama, Kenji
|
|
|
92 |
5 |
p. 381-390
|
article
|
| 4 |
Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy
|
Nakagawa, Junichi
|
|
|
92 |
5 |
p. 391-398
|
article
|
| 5 |
Mechanism of cisplatin resistance in gastric cancer and associated microRNAs
|
Liu, Changqing
|
|
|
92 |
5 |
p. 329-340
|
article
|
| 6 |
Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study
|
Ma, Yuxiang
|
|
|
92 |
5 |
p. 411-418
|
article
|
| 7 |
Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation
|
He, Shiyu
|
|
|
92 |
5 |
p. 399-410
|
article
|
| 8 |
Quantitative proteomics profiling reveals the inhibition of trastuzumab antitumor efficacy by phosphorylated RPS6 in gastric carcinoma
|
Hu, Chun-Ting
|
|
|
92 |
5 |
p. 341-355
|
article
|
Journal description